You are invited to participate in MilliporeSigma’s 2018 ADC Symposium to learn, share and discuss today’s advancements with your peers and subject matter experts of the industry.
|9:45 AM||Registration & Morning Coffee|
|10:20 AM||Welcome & Introduction|
|Advancing Development of ADCs & Bioconjugation|
|10:30 AM||Hydrophilic and Site-Specific Antibody- Drug Conjugates to Treat Tumors|
|Dr. Ping-Fu Cheng, ITRI (Taiwan)|
|11:00 AM||ABL201: an anti-BCMA antibody-drug conjugate with NTERM conjugation|
|Dr. Jinwon Jung, ABL Bio Inc.|
|11:30 AM||Creating Next Generation ADCs with Industry Leading DAR Precision and Plasma Stability|
|Dr. Jeiwook Chae, LegoChem Biosciences Inc.|
|12:00 Noon||ADCs with high DAR, high targeting valence, and product homogeneity|
|Dr. Tse Wen Chang, Immunwork Inc.|
|12:30 PM||Lunch Break|
|1:30 PM||Trends in Drug-linker Technologies: novel HPAPIs, Discrete & Activated PEGs|
|Dr. Matthias Joehnck, MilliporeSigma|
|2:00 PM||Tackling the Complex ADC Supply Chain: Best Practice Approach and Integrated Program Management Case Study|
|Latashuia Browning, MilliporeSigma|
|Technology Insights & Processing Solutions|
|2:30 PM||Evaluation of a Novel Single-use TFF Capsule|
|Yoshiaki Ogawa, MilliporeSigma|
|2:45 PM||Implementation of a Complete Single-use Production Process & Scale-up Case Study|
|Mary Robinette, MilliporeSigma|
Siyi Liao, MilliporeSigma
|3:15 PM||Demonstration of Solvent Compatibility and Extractables Profile for Use of Mobius® Assemblies in ADC Processing|
|Takao Ito, MilliporeSigma|
|3:30 PM||MLab™ Collaboration Center rotating group tours, Q&A time with experts, poster exhibition & coffee break|
|4:30 PM||Wrap-up and closing remarks|
|5:00 PM||Post-event reception|
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.
* This agenda is subject to change and will be updated during the course of the next months. The event is free; registration is mandatory and space is limited to 40 attendees. Attendance to the “2018 ADC Symposium” is limited and available to pharma/biopharma manufacturers only. The offer does not extend to any company that provides products or services to the pharma/biopharma industry. MilliporeSigma reserves the right to revoke or refuse participation at any times.
Refreshments are provided courtesy of MilliporeSigma. Travel costs, hotel accommodations and any other costs incurred are at the expense of the attendees.
The Symposium will take place at our MLab™ Collaboration Center in Tokyo Japan:
Divercity Tokyo office tower 15F